| Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice JJ Fuster, S MacLauchlan, MA Zuriaga, MN Polackal, AC Ostriker, ... Science 355 (6327), 842-847, 2017 | 1213 | 2017 |
| Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation S Muralidharan, P Mandrekar Journal of leukocyte biology 94 (6), 1167-1184, 2013 | 355 | 2013 |
| Moderate alcohol induces stress proteins HSF1 and hsp70 and inhibits proinflammatory cytokines resulting in endotoxin tolerance S Muralidharan, A Ambade, MA Fulham, J Deshpande, D Catalano, ... The Journal of Immunology 193 (4), 1975-1987, 2014 | 86 | 2014 |
| Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes S Muralidharan, PJ Hanley, E Liu, R Chakraborty, C Bollard, E Shpall, ... The Journal of Immunology 187 (10), 5221-5232, 2011 | 74 | 2011 |
| Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes MA Coleman, SP Sasi, J Onufrak, M Natarajan, K Manickam, J Schwab, ... American Journal of Physiology-Heart and Circulatory Physiology 309 (11 …, 2015 | 59 | 2015 |
| Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell … M Corbera-Bellalta, R Alba-Rovira, S Muralidharan, G Espígol-Frigolé, ... Annals of the rheumatic diseases 81 (4), 524-536, 2022 | 35 | 2022 |
| Human Binge Alcohol Intake Inhibits TLR4–MyD88 and TLR4–TRIF Responses but Not the TLR3–TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles S Muralidharan, A Lim, D Catalano, P Mandrekar The Journal of Immunology 200 (7), 2291-2303, 2018 | 29 | 2018 |
| THU0008 GM-CSF pathway signature identified in temporal artery biopsies of patients with giant cell arteritis MC Cid, R Gandhi, M Corbera-Bellalta, S Muralidharan, JF Paolini Annals of the Rheumatic Diseases 78 (Suppl 2), 271-272, 2019 | 19 | 2019 |
| BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity TL Hickman, E Choi, KR Whiteman, S Muralidharan, T Pai, T Johnson, ... PloS One 17 (5), 2022 | 16 | 2022 |
| Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients J Marken, S Muralidharan, NV Giltiay Arthritis research & therapy 23, 1-15, 2021 | 15 | 2021 |
| Ionizing particle radiation as a modulator of endogenous bone marrow cell reprogramming: implications for hematological cancers S Muralidharan, SP Sasi, MA Zuriaga, KK Hirschi, CD Porada, ... Frontiers in oncology 5, 231, 2015 | 15 | 2015 |
| FRI0010 GM-CSFR pathway is implicated in pathogenic inflammatory mechanisms in giant cell arteritis MC Cid, S Muralidharan, M Corbera-Bellalta, G Espigol-Frigole, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 576-576, 2020 | 9 | 2020 |
| Particle Radiation‐Induced Nontargeted Effects in Bone‐Marrow‐Derived Endothelial Progenitor Cells SP Sasi, D Park, S Muralidharan, J Wage, A Kiladjian, J Onufrak, ... Stem Cells International 2015 (1), 496512, 2015 | 8 | 2015 |
| Preclinical immunopharmacologic assessment of KPL-404, a novel, humanized, non-depleting antagonistic anti-CD40 monoclonal antibody S Muralidharan, M Njenga, T Garron, K Bondensgaard, JF Paolini Journal of Pharmacology and Experimental Therapeutics 381 (1), 12-21, 2022 | 6 | 2022 |
| Reduction of transplant vasculopathy by intraoperative nucleic acid-based therapy in a mouse aortic allograft model R Arif, M Franz, A Remes, M Zaradzki, M Hecker, M Karck, OJ Müller, ... The Thoracic and cardiovascular surgeon 67 (06), 503-512, 2019 | 5 | 2019 |
| Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma S Muralidharan, T Kervarrec, GJ Weiss, M Samimi Oncotarget 13, 960, 2022 | 2 | 2022 |
| BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved antitumor activity TL Hickman, E Choi, KR Whiteman, S Muralidharan, T Pai, T Johnson, ... bioRxiv, 2021.11. 17.469041, 2021 | 2 | 2021 |
| 238 Exogenous GOT2 in CAR-T cells improves metabolic function and preserves early memory T cell subsets J Hinds, S Muralidharan, A Ranger, J Coccia, T Giordano, E Kuiper, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Glypican-3 immunohistochemistry precision, validation, and prevalence in selected solid tumors to identify target populations for CAR T cell therapy GJ Weiss, A Jensen-Smith, S Muralidharan Cancer Research 82 (12), 2022 | | 2022 |
| Increased Expression of Oncostatin M Receptor β in Chronic Pruritic Diseases R Gandhi, A De Benedetto, S Muralidharan, J Ring, I Torres, T Berger, ... Journal of Investigative Dermatology 139 (9), S283-S283, 2019 | | 2019 |
